Login

The mission to digitise, democratise, and decarbonise supply chains|Shereen Zarkani,Managing Partner and Head of Maersk Growth,Maersk Growth 00:10:00

Share On Facebook Share On Twitter

Previously the VP and Global Head of Maersk

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Jonathan Rauch: Defending Free Thought in Modern Times|Jonathan Rauch,Professor,Institution in Washington
00:10:00
Avadel's Innovations and Future Plans in Healthcare | Gregory J. Divis, CEO, Avadel Pharmaceuticals PLC
00:10:00
EY CEO Carmine Di Sibio on Current Economic Trends and AI Adoption | Carmine Di Sibio, CEO , Ernst & Young.
00:00:00
Allergy Therapeutics says US preparations are underway which include two pivotal trials - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
The Evolution of Habeas Corpus from Magna Carta to the English Habeas Corpus Act of 1679|Amanda Tyler
00:10:00
Howard Capital Management, Inc. (HCM) is a SEC-Registered Investment Advisory Firm founded by Vance Howard, which offers professional money management services to private clients, financial advisors, and registered investment advisors through a suite of s
00:00:00
Alligator Bioscience - CEO Statement - Søren Bregenholt , CEO, Alligator Bioscience
00:10:00
Mineral Investindo Tbk Partners with ADMR | Harry Kesuma Tanoto, CEO of Pt Cita Mineral Investindo Tbk
00:10:00
Keith McKnight Talks Advancements at Dolphin Tungsten Mine on Tasmania’s King Island | Keith McKnight, CEO , Group 6 Metals Ltd.
00:10:00
Snowline Gold's High-Grade Yukon Discoveries
00:10:00
Canada Boosts Venture Capital with New Technology Investment Funds"
00:10:00
Alejandro Martín Introduces Horos Asset Management: Innovating the Art of Value Investing

© 2017 - Neuhu+